Close Menu
NEW YORK (GenomeWeb News) – Palo Alto, Calif.-based nanoproteomics company Cell Biosciences announced today that it has placed a prototype of a next-generation protein analysis system at Stanford University’s School of Medicine.
 
The company said that David Hirschberg, director of Stanford’s Human Immune Monitoring Center, will use Cell Biosciences’ CB1000 system for analyzing human clinical samples and will provide feedback aimed at improving product design and optimizing system features.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
17
Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.